Novanta Inc. (NOVT)
NasdaqGS
Price as at 1 Oct 2026, 15:16 UTC. Quotes are delayed.
Fundamentals
Valuation and ratings
Novanta Inc. trades at $142.95. We do not hold enough of the inputs to value this company with the confidence the estimate implies, so we publish no fair value for it rather than a number we would not defend.
About Novanta Inc.
Novanta Inc., together with its subsidiaries, provides precision medicine, precision manufacturing, medical solutions, robotics and automation solutions, and advanced surgery solutions in the United States and internationally. The company operates Automation Enabling Technologies and Medical Solutions segments. The Precision Medicine and Manufacturing segment designs, manufactures, and markets laser beam steering and scanning solutions, laser sources, robotic and precision motion, robotic end-of-arm tooling, and bearing spindles. This segment serves advanced industrial processes, advanced industrial and medical robotics, other medical and life science automation applications, and medical laser procedures, such as ophthalmology applications. The Medical Solutions segment provides a range of medical grade technologies, including medical insufflators, pumps, and related disposables; imaging, identification and RFID solutions; advanced motion control solutions; and light engines, and integrated operating room technologies. The company was formerly known as GSI Group, Inc. and changed its name to Novanta Inc. in May 2016. Novanta Inc. was incorporated in 1968 and is based in Bedford, Massachusetts.
Company profile, industry and headcount are as reported by our data provider and can lag a company's own filings by a reporting period. The annual report is the authority.
Super investor ownership
11 of the funds we track reported a position in their latest SEC 13F filing. Largest first:
- Ken Griffin, CITADEL ADVISORS LLC$50.58M · 0.0% of book
- Marshall Wace, MARSHALL WACE, LLP$25.60M · 0.0% of book
- Steve Cohen, Point72 Asset Management, L.P.$24.44M · 0.0% of book
- Cliff Asness, AQR CAPITAL MANAGEMENT LLC$15.23M · 0.0% of book
- Ray Dalio, Bridgewater Associates, LP$14.62M · 0.1% of book
A word of warning on reading these figures: a 13F reports the market value of a holding, so a fund that traded nothing at all still appears to have sold when the price fell. We found 102 companies where the standard reading gives the opposite answer. Only the share count is honest.
Politician trades in NOVT
We hold 6 disclosed trades in NOVT by members of Congress and executive-branch officials. The latest 5:
- Gilbert Cisneros · HouseBuy · $1,001 - $15,000 · traded 18 May 2026 · disclosed 8 Jun 2026
- Gilbert Cisneros · HouseBuy · $1,001 - $15,000 · traded 13 Nov 2025 · disclosed 15 Dec 2025
- Gilbert Cisneros · HouseBuy · $1,001 - $15,000 · traded 22 Oct 2019 · disclosed 15 Nov 2019
- Gilbert Cisneros · HouseBuy · $1,001 - $15,000 · traded 1 Aug 2019 · disclosed 19 Aug 2019
- Gilbert Cisneros · HouseBuy · $1,001 - $15,000 · traded 22 May 2019 · disclosed 18 Jun 2019
A disclosure reports a value band, not an amount, and is due up to 45 days after the trade; some arrive later. Every filer we track, each with their own page, is on the Congress trading tracker.
Common questions
Which funds own NOVT?
11 of the institutions we track reported a position in NOVT in their most recent SEC 13F filing. A 13F is filed up to 45 days after quarter end, so it tells you what a fund held then, not what it holds now.
Where does SteadyShares get its NOVT data?
Fundamentals for NOVT come from company filings and exchange data, as listed on NasdaqGS; institutional ownership comes from SEC 13F filings. The share price shown was last refreshed on 1 Oct 2026, 15:16 UTC and is delayed. Metrics we do not hold are left out of the page rather than estimated.
The full research page for NOVT, with financial statements, ownership detail, peer comparison and alerts, is free inside the app.
Data from company filings, exchange quotes and SEC EDGAR 13F disclosures. Quotes are delayed. Metrics we do not have are left out rather than estimated. Educational information, not financial advice.